PEN Q3 2022 Earnings — Penumbra, Inc. Revenue & Financial Results | Market Cap Arena

PENPenumbra, Inc.

$13B

Q3 2022 Earnings

Healthcare Medical - Devices

Income Statement

Revenue

$214M+12.4% YoY

Gross Profit

$135M63.3% margin

Operating Income

$5M2.5% margin

Net Income

-$2M-1.1% margin

EPS (Diluted)

$-0.06

QoQ Revenue Growth

+2.6%

Cash Flow

Operating Cash Flow

-$13M

Free Cash Flow

-$19M

Stock-Based Comp.

$10M

Balance Sheet

Total Assets

$1.3B

Total Liabilities

$348M

Stockholders' Equity

$974M

Cash & Equivalents

$55M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$214M	$190M	+12.4%
Gross Profit	$135M	$120M	+12.9%
Operating Income	$5M	$9M	-38.1%
Net Income	-$2M	$9M	-125.7%

Revenue Segments

Peripheral Vascular

$123M58%

Neuro

$90M42%

Geographic Segments

UNITED STATES

$149M70%

Other Non-US

$65M30%